NASDAQ:AFIB

Acutus Medical (AFIB) Stock Forecast, Price & News

$0.82

+0.02 (+2.50%)

(As of 06/7/2023 ET)

Compare

Today's Range: $0.80
▼
$0.89
50-Day Range: $0.66
▼
$1.02
52-Week Range: $0.48
▼
$2.15

Volume: 49,110 shs
Average Volume: 153,149 shs
Market Capitalization: $23.79 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $2.00

Acutus Medical MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 143.7% Upside
$2.00 Price Target
Short Interest: Healthy
2.55% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($2.39) to ($1.51) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.88 out of 5 stars

Medical Sector

650th out of 981 stocks

Surgical & Medical Instruments Industry

62nd out of 99 stocks

3.3

Analyst's Opinion

Consensus Rating
Acutus Medical has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $2.00, Acutus Medical has a forecasted upside of 143.7% from its current price of $0.82.
Amount of Analyst Coverage
Acutus Medical has received no research coverage in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
2.55% of the float of Acutus Medical has been sold short.
Short Interest Ratio / Days to Cover
Acutus Medical has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Acutus Medical has recently increased by 6.34%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Acutus Medical does not currently pay a dividend.
Dividend Growth
Acutus Medical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for AFIB.

0.0

News and Social Media Coverage

Search Interest
Only 1 people have searched for AFIB on MarketBeat in the last 30 days. This is a decrease of -91% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Acutus Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Acutus Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
24.30% of the stock of Acutus Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 36.32% of the stock of Acutus Medical is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Acutus Medical are expected to grow in the coming year, from ($2.39) to ($1.51) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Acutus Medical is -1.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Acutus Medical is -1.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Acutus Medical has a P/B Ratio of 0.31. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Acutus Medical (NASDAQ:AFIB) Stock

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Receive AFIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter.

AFIB Stock News Headlines

May 30, 2023 | americanbankingnews.com

Short Interest in Acutus Medical, Inc. (NASDAQ:AFIB) Increases By 6.3%

May 16, 2023 | finance.yahoo.com

Acutus Medical, Inc. (NASDAQ:AFIB) Q1 2023 Earnings Call Transcript

June 8, 2023 | Edge On The Street (Ad)

New "Mined in America" Lithium Opportunities?

The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.

May 15, 2023 | finance.yahoo.com

Acutus Medical to Showcase Innovative Cardiac Mapping and Ablation Technologies at HRS 2023

May 12, 2023 | finance.yahoo.com

Q1 2023 Acutus Medical Inc Earnings Call

May 11, 2023 | msn.com

Acutus Medical: Q1 Earnings Insights

May 11, 2023 | finance.yahoo.com

Acutus Medical Reports First Quarter 2023 Financial Results

May 9, 2023 | americanbankingnews.com

Acutus Medical (AFIB) to Release Earnings on Thursday

June 8, 2023 | Edge On The Street (Ad)

Graphite Shortage Could Derail the $7 Trillion EV Transition

Graphite (not lithium) is expected to see the largest increase in demand of all battery metals over the next decade. But projections warn of an 8 million ton shortfall of graphite by 2040. That's why 97 more graphite mines are needed just to keep up with battery production for the $7 trillion transition to electric vehicles.

April 30, 2023 | americanbankingnews.com

Acutus Medical (NASDAQ:AFIB) Trading Up 2.7%

April 28, 2023 | finance.yahoo.com

Acutus Medical to Announce First Quarter 2023 Financial Results

April 20, 2023 | seekingalpha.com

Acutus Medical gives prelim Q1 reports

April 20, 2023 | msn.com

Acutus Medical reports prelim Q1 results

April 20, 2023 | finance.yahoo.com

RECOVER AF Study Reports 91% of First Redo Patients Achieved Freedom from AF at One Year After AcQMap-guided Ablation Therapy

April 20, 2023 | finance.yahoo.com

Acutus Medical Announces Preliminary Unaudited First Quarter 2023 Results

April 20, 2023 | msn.com

Catheter ablation for A-fib may reduce risk of mental decline, dementia

April 17, 2023 | finance.yahoo.com

Acutus Medical, Inc. (NASDAQ:AFIB) Might Not Be As Mispriced As It Looks After Plunging 25%

April 1, 2023 | americanbankingnews.com

Acutus Medical, Inc. (NASDAQ:AFIB) Sees Significant Increase in Short Interest

March 22, 2023 | markets.businessinsider.com

BTIG Sticks to Its Buy Rating for Acutus Medical (AFIB)

March 18, 2023 | markets.businessinsider.com

BTIG Sticks to Their Buy Rating for Acutus Medical (AFIB)

March 18, 2023 | finance.yahoo.com

Acutus Medical, Inc. (NASDAQ:AFIB) Q4 2022 Earnings Call Transcript

March 16, 2023 | msn.com

Acutus Medical GAAP EPS of $0.41 beats by $1.12, revenue of $5M beats by $0.45M

March 16, 2023 | finance.yahoo.com

Acutus Medical Reports Fourth Quarter and Full Year 2022 Financial Results

March 16, 2023 | finance.yahoo.com

Acutus Medical, Inc. (AFIB) Q4 Earnings and Revenues Surpass Estimates

March 16, 2023 | marketwatch.com

Afib Heart Devices Market [2023-2028] | Latest Study on Global Industry Trends & Future Forecast

March 15, 2023 | benzinga.com

Acutus Medical's Earnings: A Preview

March 9, 2023 | finance.yahoo.com

Acutus Medical to Announce Fourth Quarter and Full Year 2022 Financial Results

See More Headlines

AFIB Price History

30 days | 90 days | 365 days | Advanced Chart

AFIB Company Calendar

Last Earnings: 3/16/2023
Today: 6/07/2023
Next Earnings (Estimated): 8/10/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:AFIB
CUSIP: N/A
CIK: 1522860
Web: www.acutusmedical.com
Phone: 442-232-6080
Fax: 442-232-6081
Employees: 291
Year Founded: 2011

Price Target and Rating

Average Stock Price Forecast: $2.00
High Stock Price Forecast: $2.50
Low Stock Price Forecast: $1.50
Forecasted Upside/Downside: +143.7%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.72)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-39,620,000.00
Net Margins: -94.43%
Pretax Margin: -93.95%
Return on Equity: -23.58%
Return on Assets: -12.67%

Debt

Debt-to-Equity Ratio: 0.57
Current Ratio: 5.95
Quick Ratio: 5.08

Sales & Book Value

Annual Sales: $16.36 million
Price / Sales: 1.45
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.64 per share
Price / Book: 0.31

Miscellaneous

Outstanding Shares: 28,980,000
Free Float: 21,935,000
Market Cap: $23.79 million
Optionable: Not Optionable
Beta: 0.81

Social Links

Key Executives

Mr. R. Scott Huennekens CPA (Age 58)
M.B.A., Exec. Chairman
Comp: $121k

Mr. David Harrison Roman (Age 40)
CEO, Pres & Director
Comp: $679.4k

Mr. Vincent J. Burgess (Age 57)
Consultant
Comp: $583.5k

Mr. Takeo Mukai
VP of Fin. & Accounting and Interim CFO

Dr. Graydon E. Beatty (Age 65)
Chief Technology Officer

Dr. Derrick Chou Ph.D.
Chief Technology Officer

Mr. Tom Sohn (Age 47)
Sr. VP, Gen. Counsel & Sec.

Mr. Shibaji Shome Ph.D.
VP of Marketing

Mr. Charlie Piscitello (Age 59)
Sr. VP & Chief People Officer

Mr. Gary W. Doherty (Age 56)
Sr. VP of Fin.

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

AFIB Stock - Frequently Asked Questions

Should I buy or sell Acutus Medical stock right now?: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Acutus Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AFIB shares.
View AFIB analyst ratings or view top-rated stocks.
What is Acutus Medical's stock price forecast for 2023?: 2 analysts have issued 12 month price objectives for Acutus Medical's shares. Their AFIB share price forecasts range from $1.50 to $2.50. On average, they expect the company's share price to reach $2.00 in the next year. This suggests a possible upside of 143.7% from the stock's current price.
View analysts price targets for AFIB or view top-rated stocks among Wall Street analysts.
How have AFIB shares performed in 2023?: Acutus Medical's stock was trading at $1.15 at the beginning of 2023. Since then, AFIB stock has decreased by 28.6% and is now trading at $0.8208.
View the best growth stocks for 2023 here.
Are investors shorting Acutus Medical?: Acutus Medical saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 493,200 shares, an increase of 6.3% from the April 30th total of 463,800 shares. Based on an average daily trading volume, of 133,900 shares, the days-to-cover ratio is currently 3.7 days. Approximately 2.6% of the shares of the company are short sold.
View Acutus Medical's Short Interest.
When is Acutus Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our AFIB earnings forecast.
How were Acutus Medical's earnings last quarter?: Acutus Medical, Inc. (NASDAQ:AFIB) released its quarterly earnings results on Thursday, March, 16th. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.70) by $1.11. The firm had revenue of $4.96 million for the quarter, compared to analysts' expectations of $4.80 million. Acutus Medical had a negative net margin of 94.43% and a negative trailing twelve-month return on equity of 23.58%.
What guidance has Acutus Medical issued on next quarter's earnings?: Acutus Medical issued an update on its FY 2023 earnings guidance on Friday, May, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $19.00 million-$21.00 million, compared to the consensus revenue estimate of $19.64 million.
What other stocks do shareholders of Acutus Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Acutus Medical investors own include Oak Street Health (OSH), Alibaba Group (BABA), Checkmate Pharmaceuticals (CMPI), Salesforce (CRM), Walt Disney (DIS), DocuSign (DOCU), Marvell Technology (MRVL), NVIDIA (NVDA), Tesla (TSLA) and Twilio (TWLO).

When did Acutus Medical IPO?: (AFIB) raised $126 million in an initial public offering on Thursday, August 6th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.
What is Acutus Medical's stock symbol?: Acutus Medical trades on the NASDAQ under the ticker symbol "AFIB."
Who are Acutus Medical's major shareholders?: Acutus Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (1.36%), Schonfeld Strategic Advisors LLC (0.59%), Cerity Partners LLC (0.22%) and Belvedere Trading LLC (0.00%). Insiders that own company stock include James F Hinrichs, Orbimed Advisors Llc and R Scott Huennekens.
View institutional ownership trends.
How do I buy shares of Acutus Medical?: Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Acutus Medical's stock price today?: One share of AFIB stock can currently be purchased for approximately $0.82.
How much money does Acutus Medical make?: Acutus Medical (NASDAQ:AFIB) has a market capitalization of $23.79 million and generates $16.36 million in revenue each year. The company earns $-39,620,000.00 in net income (profit) each year or ($0.72) on an earnings per share basis.
How many employees does Acutus Medical have?: The company employs 291 workers across the globe.
Does Acutus Medical have any subsidiaries?: The following companies are subsidiares of Acutus Medical: Acutus Medical N.V..
Read More
How can I contact Acutus Medical?: Acutus Medical's mailing address is 2210 FARADAY AVE SUITE 100, CARLSBAD CA, 92008. The official website for the company is www.acutusmedical.com. The company can be reached via phone at 442-232-6080, via email at investors@acutusmedical.com, or via fax at 442-232-6081.

This page (NASDAQ:AFIB) was last updated on 6/8/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial